Literature DB >> 15578726

Molecular basis of human glutamate dehydrogenase regulation under changing energy demands.

Vasileios Mastorodemos1, Ioannis Zaganas, Cleanthe Spanaki, Maria Bessa, Andreas Plaitakis.   

Abstract

Glutamate dehydrogenase (GDH), an enzyme central to glutamate metabolism, is located in the mitochondria although there is evidence for extramitochondrial localization of GDH. In the human, housekeeping and nerve tissue-specific isoforms, encoded by the GLUD1 and GLUD2 genes, have been identified. The two isoenzymes differ markedly in their baseline activities, allosteric regulation, and thermal stability. GTP potently inhibits GLUD1-derived GDH (IC(50) = 0.2 muM), whereas the GLUD2-derived isoenzyme is resistant to this compound. The GLUD2-derived GDH shows low basal activity and has the capacity to be activated fully by ADP or L-leucine. We used molecular biological tools to study the subcellular localization of GLUD1-derived GDH in cultured cells and the molecular basis of its regulation. COS7 cells, transfected with a GLUD1-pEGFP-N3 vector, revealed a GFP fluorescence pattern nearly identical to that of the mitochondrial marker pDsRed2-Mito. Site-directed mutagenesis of GLUD1 gene showed that replacement of Gly456 by Ala made the enzyme resistant to GTP (IC(50) = 2.8 +/- 0.15 microM) without altering its regulation by ADP. Substitution of Ser for Arg443 rendered the enzyme virtually inactive at its basal state, but fully responsive to ADP activation. The Arg443Ser mutant was more active at pH 7.0 than at pH 8.0. The Gly456Ala change therefore dissociated GLUD2-derived GDH function from GTP, whereas the Arg443Ser change made enzyme regulation possible without this inhibitor. These properties may allow the brain isoenzyme to function well under conditions of intracellular acidification and increased turnover of ATP to ADP, as occurs in synaptic astrocytes during excitatory transmission. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15578726     DOI: 10.1002/jnr.20353

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  32 in total

1.  Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation.

Authors:  Ljubica Harhaji-Trajkovic; Katarina Arsikin; Tamara Kravic-Stevovic; Sasa Petricevic; Gordana Tovilovic; Aleksandar Pantovic; Nevena Zogovic; Biljana Ristic; Kristina Janjetovic; Vladimir Bumbasirevic; Vladimir Trajkovic
Journal:  Pharm Res       Date:  2012-04-27       Impact factor: 4.200

Review 2.  N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.

Authors:  John R Moffett; Brian Ross; Peethambaran Arun; Chikkathur N Madhavarao; Aryan M A Namboodiri
Journal:  Prog Neurobiol       Date:  2007-01-05       Impact factor: 11.685

3.  Selective galactose culture condition reveals distinct metabolic signatures in pyruvate dehydrogenase and complex I deficient human skin fibroblasts.

Authors:  Damian Hertig; Andrea Felser; Gaëlle Diserens; Sandra Kurth; Peter Vermathen; Jean-Marc Nuoffer
Journal:  Metabolomics       Date:  2019-02-28       Impact factor: 4.290

4.  A critical role for peroxisomal proliferator-activated receptor-alpha nuclear receptors in the development of cardiomyocyte degeneration and necrosis.

Authors:  Ingrid Pruimboom-Brees; Mehrdad Haghpassand; Lori Royer; Dominique Brees; Charles Aldinger; William Reagan; Jatinder Singh; Roy Kerlin; Christopher Kane; Scott Bagley; Cheryl Hayward; James Loy; Peter O'Brien; Omar L Francone
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 5.  The role of glutamate dehydrogenase in mammalian ammonia metabolism.

Authors:  Cleanthe Spanaki; Andreas Plaitakis
Journal:  Neurotox Res       Date:  2011-10-29       Impact factor: 3.911

6.  Multifactorial Gene Therapy Enhancing the Glutamate Uptake System and Reducing Oxidative Stress Delays Symptom Onset and Prolongs Survival in the SOD1-G93A ALS Mouse Model.

Authors:  Chen Benkler; Yael Barhum; Tali Ben-Zur; Daniel Offen
Journal:  J Mol Neurosci       Date:  2015-12-21       Impact factor: 3.444

7.  Genes to treat excitotoxicity ameliorate the symptoms of the disease in mice models of multiple system atrophy.

Authors:  Micaela Johanna Glat; Nadia Stefanova; Gregor Karl Wenning; Daniel Offen
Journal:  J Neural Transm (Vienna)       Date:  2020-02-17       Impact factor: 3.575

Review 8.  Heterogeneous cellular distribution of glutamate dehydrogenase in brain and in non-neural tissues.

Authors:  Cleanthe Spanaki; Dimitra Kotzamani; Zoe Petraki; Elias Drakos; Andreas Plaitakis
Journal:  Neurochem Res       Date:  2014-01-17       Impact factor: 3.996

Review 9.  Development of mice with brain-specific deletion of floxed glud1 (glutamate dehydrogenase 1) using cre recombinase driven by the nestin promoter.

Authors:  Melis Karaca; Pierre Maechler
Journal:  Neurochem Res       Date:  2013-04-18       Impact factor: 3.996

Review 10.  Metabolic and regulatory roles of leucine in neural cells.

Authors:  Radovan Murín; Bernd Hamprecht
Journal:  Neurochem Res       Date:  2007-08-25       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.